Yes, Lithium Causes Nausea
Nausea is a well-established adverse effect of lithium therapy, occurring both as an early side effect during treatment initiation and as a warning sign of lithium toxicity.
Nausea as an Early Side Effect
According to the FDA drug label, transient and mild nausea may appear during the first few days of lithium administration 1. This early nausea:
- Typically occurs alongside general discomfort
- Usually represents "an inconvenience rather than a disabling condition"
- Generally subsides with continued treatment or temporary dose reduction
- Does not necessarily indicate toxicity when occurring at therapeutic levels
Nausea as a Toxicity Warning Sign
More importantly, nausea serves as an early warning sign of lithium toxicity 1. The FDA label explicitly states that diarrhea, vomiting, drowsiness, muscular weakness and lack of coordination may be early signs of lithium toxicity, and can occur at lithium levels below 2 mEq/L 1.
Clinical Context of Toxicity-Related Nausea
Recent case series demonstrate that gastrointestinal symptoms including nausea and vomiting are commonly reported in lithium toxicity cases 2. In elderly patients particularly, the combination of nausea, vomiting, and diarrhea can trigger dehydration, which further elevates lithium levels and creates a dangerous cycle 3.
Practical Clinical Approach
When a patient on lithium presents with nausea:
For new-onset nausea in early treatment:
- Consider temporary dose reduction
- Monitor for resolution over days
- Ensure adequate hydration
- Check serum lithium level if symptoms persist
For nausea in established therapy:
- Immediately check serum lithium level - toxicity can occur even at therapeutic or near-therapeutic concentrations 2
- Assess for dehydration, recent medication changes (NSAIDs, diuretics, ACE inhibitors), or acute illness
- Evaluate renal function (creatinine, BUN)
- Look for accompanying neurological signs: tremor (most common at 61.9%), altered mental status, ataxia, or speech disturbances 2
Critical Pitfall
Do not dismiss nausea as benign in patients on chronic lithium therapy. The likelihood of toxicity increases with serum levels above 1.5 mEq/L, but clinically significant toxicity can occur at lower levels, particularly in elderly patients or those with declining renal function 1, 2. Approximately two-thirds of toxicity cases show elevated creatinine 2, and declining renal function with reduced volume of distribution in elderly patients contributes to increased pharmacological toxicity 3.
The gastrointestinal symptoms (nausea, vomiting, diarrhea) may be both cause and consequence of toxicity - they can trigger dehydration leading to elevated lithium levels, while simultaneously being manifestations of that toxicity 3.